Global Endowment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-83,200
Closed -$4.01M 180
2019
Q1
$4.01M Buy
83,200
+72,500
+678% +$3.63M 0.57% 36
2018
Q4
$477K Sell
10,700
-111,900
-91% -$5.83M 0.1% 98
2018
Q3
$6.62M Buy
122,600
+5,500
+5% +$281K 0.88% 27
2018
Q2
$5.72M Buy
117,100
+55,100
+89% +$3.12M 0.75% 39
2018
Q1
$3.89M Buy
62,000
+5,100
+9% +$350K 0.56% 42
2017
Q4
$3.49M Buy
56,900
+5,800
+11% +$359K 0.51% 41
2017
Q3
$3.42M Buy
+51,100
New +$3.61M 0.48% 36

Other funds holding CAH

Global Endowment Management's CAH Position: Q2 2019 in Review

Global Endowment Management sold out of Cardinal Health (CAH) in Q2 2019, closing a stake of 83,200 shares — an estimated $4.01M sold.

Global Endowment Management first reported a position in CAH in Q3 2017 and held it in 7 quarters. The position peaked at $6.62M in Q3 2018. 686 funds tracked by Wall St. Rank hold CAH as of Q2 2019.

  • Global Endowment Management reported no remaining Cardinal Health position as of Q2 2019 after selling out during the quarter.
  • Global Endowment Management sold 83,200 Cardinal Health shares in Q2 2019, an estimated $4.01M.
  • Global Endowment Management first reported a position in Cardinal Health in Q3 2017 and held it in 7 quarters.
  • Global Endowment Management's Cardinal Health position peaked at $6.62M in Q3 2018.
  • 686 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2019.

Based on Global Endowment Management's 13F filing for Q2 2019, filed 12 Aug 2019.